|
Real-time
OTC Markets
15:59:53 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+8.12% | -10.38% |
Evolution of the Average Target: Northwest Biotherapeutics, Inc.
Evolution of the Target Price: Northwest Biotherapeutics, Inc.
Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.
15e2e94d5951d10460.cZX4kCvti-lEBpezJDTvO0ajIiapspBH5LVYKkGTEh0.JaGb6Ee7voYHQ8f8ZmWkdA_oTHnD3MYunfoAW3jURnNBz4_Jar-4vHRlow~20f365ce9243e36f136b8c735df85338
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +489.45% | |||
| +21.09% | |||||
| +11.95% | |||||
| +58.51% | |||||
| +15.94% | |||||
| +16.61% | |||||
| +12.11% | |||||
| +6.66% | |||||
| +26.36% | |||||
| -9.02% | |||||
| Average | +64.97% | |||||
| Weighted average by Cap. | +19.43% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1696USD
Average target price
1.000USD
Spread / Average Target
+489.45%
High Price Target
1.000USD
Spread / Highest target
+489.45%
Low Price Target
1.000USD
Spread / Lowest Target
+489.45%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- NWBO Stock
- Consensus Northwest Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
